Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors | Medical Journals and Publishing | JAMA | JAMA Network

peter.suber's bookmarks 2021-02-02

Summary:

"The International Committee of Medical Journal Editors (ICMJE) believes there is an ethical obligation to responsibly share data generated by interventional clinical trials because trial participants have put themselves at risk. In January 2016 we published a proposal aimed at helping to create an environment in which the sharing of deidentified individual participant data becomes the norm. In response to our request for feedback we received many comments from individuals and groups.1 Some applauded the proposal while others expressed disappointment it did not more quickly create a commitment to data sharing. Many raised valid concerns regarding the feasibility of the proposed requirements, the necessary resources, the real or perceived risks to trial participants, and the need to protect the interests of patients and researchers.

It is encouraging that data sharing is already occurring in some settings. Over the past year, however, we have learned that the challenges are substantial and the requisite mechanisms are not in place to mandate universal data sharing at this time. Although many issues must be addressed for data sharing to become the norm, we remain committed to this goal.

Therefore, ICMJE will require the following as conditions of consideration for publication of a clinical trial report in our member journals:..."

Link:

https://jamanetwork.com/journals/jama/fullarticle/2630773

Updated:

02/02/2021, 11:24

From feeds:

Open Access Tracking Project (OATP) ┬╗ peter.suber's bookmarks

Tags:

oa.data oa.medicine oa.clinical_trials oa.icmje oa.journals oa.mandates oa.policies oa.policies.journals oa.policies.journals.data oa.pharma

Date tagged:

02/02/2021, 16:24

Date published:

06/27/2017, 12:24